(As of October 7, 2011)
NAME |
ROLE |
NOTHING TO DISCLOSE |
DISCLOSURE |
Mark Forrestal, MD, FACPh |
AVLS |
|
CoolTouch: Stockholder |
Jean-Jerome Guex, MD, FACPh |
AVLS |
|
Innotech International- Investigator; Pierre Fabre: Consultant; Sigvaris: Investigator; Vascular Insights, |
Mark Isaacs, MD, FACPh, FAAFP |
AVLS |
|
Covidien: Stockholder, |
Lowell Kabnick, MD, FACS, FACPh |
AVLS |
|
Angiodynamics: Consultant, Scientific Advisory, Stockholder; Merz: Speaker; Vascular Insights LLC: Consultant, Scientific |
Neil Khilnani, MD, FACPh |
AVLS |
|
Sapheon: Consultant |
John Mauriello, MD, FACPh |
AVLS |
|
Angiodynamics: Speaker; |
Mark Meissner, MD |
AVLS |
X |
|
Nick Morrison, MD, FACS, FACPh |
AVLS |
|
BTG: Principal Site Investigator; Vascular Insights LLC: Scientific Advisory Board; |
Diana Neuhardt, RVT, RPhS |
AVLS |
X |
|
Lisa Pavone, MD |
AVLS |
X |
|
Melvin Rosenblatt, MD, FACPh |
AVLS |
X |
|
Bruce Sanders, CAE |
AVLS |
X |
|
Marlin Schul, MD, MBA, RVT, FACPh |
AVLS |
|
BTG: Principal Investigator |
Julianne Stoughton, MD, FACS |
AVLS |
|
Covidien: Consultant |